Income Statement Dr. Lal PathLabs Limited

Stocks

LALPATHLAB

INE600L01024

Healthcare Facilities & Services

Market Closed - NSE India S.E. Other stock markets 19:05:07 16/07/2026 HKT			5-day change	1st Jan Change
1,732.70 ^INR	+0.55%		+4.79%	+16.87%

06-17	Dr. Lal PathLabs' Volume Boom Comes at a Cost
05-04	Nomura Adjusts Dr. Lal PathLabs' Price Target to INR1,860 From INR1,800, Keeps at Buy	MT

b774c3ec741ae571adaaa640.N1-bJw3kvwk72yAP63H6JpQRw6tG1lOPO77c9leDRdQ.ACnUbWDdz1N-7HZO3hO1Sed4pZkWoRa2FsaVpRnoD_lobNRhX6XVWXKjUw

Published financial data: DR. LAL PATHLABS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	20.87B	20.17B	22.27B	24.61B	27.63B
Total Revenues	20.87B	20.17B	22.27B	24.61B	27.63B
Cost of Goods Sold, Total	9.2B	8.92B	9.48B	10.37B	11.19B
Gross Profit	11.68B	11.25B	12.79B	14.24B	16.44B
Selling General & Admin Expenses, Total	3.47B	3.58B	4.14B	4.5B	5.26B
Provision for Bad Debts	6.16M	36.47M	-	11.25M	8.79M
Depreciation & Amortization - (IS)	1.08B	1.5B	1.44B	1.42B	1.62B
Other Operating Expenses	2.57B	2.73B	2.54B	2.72B	3.29B
Other Operating Expenses, Total	7.13B	7.85B	8.11B	8.65B	10.18B
Operating Income	4.55B	3.4B	4.68B	5.59B	6.26B
Interest Expense, Total	-302M	-375M	-294M	-223M	-228M
Interest And Investment Income	473M	332M	554M	665M	670M
Net Interest Expenses	171M	-43.52M	261M	442M	442M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	1.27M	1.02M	1.24M	22.35M	20.9M
EBT, Excl. Unusual Items	4.72B	3.36B	4.94B	6.06B	6.72B
Gain (Loss) On Sale Of Investments	31.62M	64.21M	104M	209M	277M
Gain (Loss) On Sale Of Assets	-6M	8.07M	-2.18M	-21.51M	-9.15M
Other Unusual Items	4.95M	6.96M	9.29M	3.35M	-298M
EBT, Incl. Unusual Items	4.75B	3.44B	5.05B	6.25B	6.69B
Income Tax Expense	1.25B	1.03B	1.43B	1.33B	1.59B
Earnings From Continuing Operations	3.5B	2.41B	3.62B	4.92B	5.1B
Net Income to Company	3.5B	2.41B	3.62B	4.92B	5.1B
Minority Interest	-54.58M	-22.29M	-45.58M	-51.14M	-49.75M
Net Income - (IS)	3.45B	2.39B	3.58B	4.87B	5.05B
Net Income to Common Incl Extra Items	3.45B	2.39B	3.58B	4.87B	5.05B
Net Income to Common Excl. Extra Items	3.45B	2.39B	3.58B	4.87B	5.05B
Per Share Items
Net EPS - Basic	20.85	14.41	21.52	29.24	30.24
Basic EPS - Continuing Operations	20.85	14.41	21.52	29.24	30.24
Basic Weighted Average Shares Outstanding	165M	166M	166M	167M	167M
Net EPS - Diluted	20.78	14.37	21.49	29.2	30.2
Diluted EPS - Continuing Operations	20.78	14.37	21.49	29.2	30.2
Diluted Weighted Average Shares Outstanding	166M	166M	166M	167M	167M
Normalized Basic EPS	17.51	12.53	18.31	22.42	24.87
Normalized Diluted EPS	17.45	12.49	18.29	22.38	24.83
Dividend Per Share	6	6	12	12	14
Payout Ratio	33.83	43.13	55.76	41.03	42.99
Supplemental Items
EBITDA	5.19B	4.41B	5.67B	6.58B	7.41B
EBITA	4.78B	3.93B	5.21B	6.12B	6.84B
EBIT	4.55B	3.4B	4.68B	5.59B	6.26B
EBITDAR	5.45B	4.66B	5.94B	6.89B	7.73B
Total Revenues (As Reported)	21.4B	20.59B	22.96B	25.55B	28.64B
Effective Tax Rate - (Ratio)	26.25	29.88	28.32	21.21	23.81
Total Current Taxes	1.26B	1.08B	1.48B	1.72B	1.59B
Total Deferred Taxes	-17.88M	-51.41M	-48.67M	-395M	520K
Normalized Net Income	2.89B	2.08B	3.04B	3.73B	4.15B
Interest on Long-Term Debt	199M	223M	200M	192M	227M
Non-Cash Pension Expense	4.65M	9.9M	13.74M	62.57M	292M
Supplemental Operating Expense Items
Advertising Expense	368M	508M	733M	778M	910M
Selling and Marketing Expenses	368M	508M	733M	778M	910M
General and Administrative Expenses	2.85B	2.82B	3.13B	3.42B	4.02B
Net Rental Expense, Total	261M	249M	272M	306M	326M
Imputed Operating Lease Interest Expense	184M	157M	192M	270M	333M
Imputed Operating Lease Depreciation	76.41M	91.94M	80.19M	35.93M	-7.65M
Maintenance & Repair Expenses, Total	526M	683M	716M	735M	813M
Stock-Based Comp., COGS (Total)	323M	228M	217M	271M	238M
Total Stock-Based Compensation	323M	228M	217M	271M	238M

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	3.78B	2.64B	3.61B	2.93B	2.43B
Short Term Investments	2.38B	4.01B	4.68B	5.45B	6.65B
Trading Asset Securities, Total	655M	1.5B	1.14B	3.27B	4.23B
Total Cash And Short Term Investments	6.82B	8.14B	9.43B	11.64B	13.31B
Accounts Receivable, Total	854M	708M	774M	881M	1.11B
Other Receivables	199M	216M	315M	346M	352M
Notes Receivable	10.68M	13.64M	12.77M	11.24M	18.14M
Total Receivables	1.06B	938M	1.1B	1.24B	1.48B
Inventory	525M	338M	373M	361M	439M
Prepaid Expenses	139M	128M	164M	163M	182M
Restricted Cash	1.43M	-	-	-	-
Other Current Assets, Total	205M	184M	202M	232M	260M
Total Current Assets	8.75B	9.73B	11.27B	13.64B	15.66B
Gross Property Plant And Equipment	-	7.79B	7.95B	8.61B	11.02B
Accumulated Depreciation	-	-3.75B	-4.48B	-5.22B	-6.13B
Net Property Plant And Equipment	4.3B	4.04B	3.47B	3.39B	4.89B
Long-term Investments	-	-	-	-	-
Goodwill	5.5B	5.48B	5.48B	5.48B	5.48B
Other Intangibles, Total	4.11B	3.58B	3.04B	2.51B	1.93B
Loans Receivable Long-Term	1.07M	560K	320K	40K	1.11M
Deferred Tax Assets Long-Term	370M	404M	449M	866M	875M
Other Long-Term Assets, Total	506M	620M	849M	1.28B	2.62B
Total Assets	23.53B	23.86B	24.56B	27.17B	31.46B
Liabilities
Accounts Payable, Total	1.47B	1.56B	1.87B	1.99B	1.81B
Accrued Expenses, Total	410M	405M	503M	567M	866M
Short-term Borrowings	954M	700M	-	-	-
Current Portion of Long-Term Debt	834M	833M	833M	-	-
Current Portion of Leases	481M	528M	606M	548M	536M
Current Income Taxes Payable	31.56M	4.97M	133M	138M	70.78M
Unearned Revenue Current, Total	94.92M	97.19M	117M	123M	145M
Other Current Liabilities	721M	567M	595M	658M	1.08B
Total Current Liabilities	5B	4.7B	4.65B	4.02B	4.51B
Long-Term Debt	1.67B	833M	-	-	-
Long-Term Leases	1.39B	1.3B	1.03B	1.03B	1.45B
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	-	-	-	19.47M	26.48M
Deferred Tax Liability Non Current	40.39M	29.41M	23.92M	33.73M	60.28M
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	8.1B	6.86B	5.71B	5.1B	6.05B
Common Stock, Total	833M	834M	835M	836M	1.68B
Additional Paid In Capital	928M	935M	1.05B	1.25B	828M
Retained Earnings	12.93B	14.53B	16.34B	20.05B	23.12B
Treasury Stock	-162M	-119M	-144M	-195M	-420M
Comprehensive Income and Other	554M	482M	410M	-216M	-119M
Total Common Equity	15.08B	16.66B	18.49B	21.73B	25.08B
Minority Interest	355M	332M	361M	338M	331M
Total Equity	15.44B	17B	18.85B	22.06B	25.41B
Total Liabilities And Equity	23.53B	23.86B	24.56B	27.17B	31.46B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	166M	166M	166M	167M	167M
ECS Total Common Shares Outstanding	166M	166M	166M	167M	167M
Book Value / Share	91.11	100.45	111.12	130.31	150.21
Tangible Book Value	5.48B	7.6B	9.97B	13.74B	17.67B
Tangible Book Value Per Share	33.08	45.83	59.89	82.38	105.84
Total Debt	5.33B	4.19B	2.47B	1.57B	1.99B
Net Debt	-1.49B	-3.95B	-6.96B	-10.07B	-11.32B
Debt Equivalent of Unfunded Proj. Benefit Obligation	157M	188M	261M	231M	562M
Debt Equivalent Oper. Leases	2.08B	1.99B	2.17B	2.45B	2.61B
Minority Interest, Total (Incl. Fin. Div)	355M	332M	361M	338M	331M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Others	525M	338M	373M	361M	439M
Land - (BS)	-	110M	110M	110M	110M
Buildings, Total	-	554M	555M	555M	1.35B
Machinery, Total	-	3.05B	3.29B	3.62B	4.29B
Full Time Employees	4.11K	4.05K	4.1K	4.98K	5.21K
Accumulated Allowance for Doubtful Accounts (Supple)	285M	345M	315M	288M	307M

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	3.45B	2.39B	3.58B	4.87B	5.05B
Depreciation & Amortization - CF	780M	898M	834M	812M	970M
Amortization of Goodwill and Intangible Assets - (CF)	228M	532M	533M	532M	578M
Depreciation & Amortization, Total	1.01B	1.43B	1.37B	1.34B	1.55B
Amortization of Deferred Charges, Total - (CF)	73.35M	72.26M	68.25M	75.29M	70.1M
(Gain) Loss From Sale Of Asset	6M	-8.07M	2.18M	21.51M	9.15M
(Gain) Loss on Sale of Investments - (CF)	-31.62M	-64.21M	-104M	-209M	-277M
Stock-Based Compensation (CF)	323M	228M	217M	271M	238M
Provision and Write-off of Bad Debts	-6.96M	112M	7.18M	45.73M	42.39M
Other Operating Activities, Total	-186M	46.92M	-140M	-791M	-588M
Change In Accounts Receivable	-180M	33.35M	-72.96M	-153M	-268M
Change In Inventories	-99.83M	187M	-35.01M	11.75M	-77.23M
Change In Accounts Payable	34.33M	92.27M	305M	123M	135M
Change in Other Net Operating Assets	78.42M	41.78M	161M	78.5M	476M
Cash from Operations	4.47B	4.56B	5.35B	5.69B	6.36B
Capital Expenditure	-941M	-365M	-512M	-443M	-1.67B
Sale of Property, Plant, and Equipment	16.47M	5.03M	8.76M	6.74M	5.4M
Cash Acquisitions	-4.58B	-178M	-3.54M	-	-
Sale (Purchase) of Intangible assets	-3.82B	-80.51M	-62.67M	-95.8M	-63.63M
Investment in Marketable and Equity Securities, Total	4.33B	-2.56B	-147M	-3.17B	-3.19B
Other Investing Activities, Total	496M	306M	473M	666M	698M
Cash from Investing	-4.49B	-2.87B	-243M	-3.03B	-4.22B
Long-Term Debt Issued, Total	3.45B	-	-	-	-
Total Debt Issued	3.45B	-	-	-	-
Long-Term Debt Repaid, Total	-621M	-1.43B	-1.87B	-1.17B	-368M
Total Debt Repaid	-621M	-1.43B	-1.87B	-1.17B	-368M
Issuance of Common Stock	1.38M	8.72M	34.88M	127M	186M
Issuance of Preferred Stock	-	-	-	-	-
Common Dividends Paid	-1.17B	-1.03B	-1.99B	-2B	-2.17B
Common & Preferred Stock Dividends Paid	-1.17B	-1.03B	-1.99B	-2B	-2.17B
Other Financing Activities, Total	-304M	-379M	-311M	-297M	-284M
Cash from Financing	1.36B	-2.83B	-4.14B	-3.34B	-2.64B
Miscellaneous Cash Flow Adjustments	-10K	-	-	-	-
Net Change in Cash	1.34B	-1.14B	972M	-683M	-498M
Supplemental Items
Cash Interest Paid	304M	377M	294M	223M	228M
Cash Income Tax Paid (Refund)	1.3B	1.06B	1.32B	1.64B	1.75B
Levered Free Cash Flow	-637M	3.43B	4.14B	4.63B	4.02B
Unlevered Free Cash Flow	-449M	3.66B	4.33B	4.77B	4.16B
Change In Net Working Capital	-66.53M	-252M	-324M	-126M	-132M
Net Debt Issued / Repaid	2.83B	-1.43B	-1.87B	-1.17B	-368M

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	14.16	8.98	12.09	13.52	13.34
Return on Total Capital	16.23	10.15	13.76	15.55	15.32
Return On Equity %	24.85	14.9	20.21	24.06	21.47
Return on Common Equity	25.05	15.08	20.35	24.22	21.57
Margin Analysis
Gross Profit Margin %	55.94	55.78	57.44	57.86	59.49
SG&A Margin	16.64	17.74	18.57	18.29	19.04
EBITDA Margin %	24.86	21.88	25.48	26.73	26.8
EBITA Margin %	22.88	19.5	23.42	24.88	24.74
EBIT Margin %	21.78	16.87	21.02	22.72	22.65
Income From Continuing Operations Margin %	16.78	11.95	16.27	20	18.45
Net Income Margin %	16.52	11.84	16.07	19.79	18.27
Net Avail. For Common Margin %	16.52	11.84	16.07	19.79	18.27
Normalized Net Income Margin	13.87	10.3	13.67	15.17	15.02
Levered Free Cash Flow Margin	-3.05	17	18.61	18.82	14.56
Unlevered Free Cash Flow Margin	-2.15	18.16	19.44	19.39	15.07
Asset Turnover
Asset Turnover	1.04	0.85	0.92	0.95	0.94
Fixed Assets Turnover	5.63	4.84	5.93	7.17	6.67
Receivables Turnover (Average Receivables)	27.45	25.82	30.04	29.74	27.79
Inventory Turnover (Average Inventory)	19.34	20.66	26.65	28.25	27.99
Short Term Liquidity
Current Ratio	1.75	2.07	2.42	3.39	3.48
Quick Ratio	1.57	1.93	2.26	3.2	3.28
Operating Cash Flow to Current Liabilities	0.89	0.97	1.15	1.41	1.41
Days Sales Outstanding (Average Receivables)	13.3	14.14	12.18	12.27	13.13
Days Outstanding Inventory (Average Inventory)	18.87	17.67	13.73	12.92	13.04
Average Days Payable Outstanding	57.22	63.43	65.93	67.89	56.3
Cash Conversion Cycle (Average Days)	-25.05	-31.62	-40.02	-42.69	-30.12
Long Term Solvency
Total Debt/Equity	34.5	24.68	13.1	7.13	7.83
Total Debt / Total Capital	25.65	19.8	11.58	6.66	7.26
LT Debt/Equity	19.8	12.55	5.46	4.65	5.72
Long-Term Debt / Total Capital	14.72	10.07	4.83	4.34	5.31
Total Liabilities / Total Assets	34.41	28.76	23.23	18.78	19.22
EBIT / Interest Expense	15.07	9.06	15.95	25.07	27.45
EBITDA / Interest Expense	18.41	12.87	20.6	31.1	34.23
(EBITDA - Capex) / Interest Expense	15.29	11.9	18.86	29.11	26.91
Total Debt / EBITDA	0.96	0.87	0.41	0.23	0.25
Net Debt / EBITDA	-0.27	-0.82	-1.15	-1.45	-1.45
Total Debt / (EBITDA - Capex)	1.15	0.94	0.45	0.24	0.32
Net Debt / (EBITDA - Capex)	-0.32	-0.88	-1.26	-1.55	-1.84
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	32.01	-3.38	10.4	10.54	12.25
Gross Profit, 1 Yr. Growth %	33.21	-3.66	13.7	11.34	13.3
EBITDA, 1 Yr. Growth %	30.08	-14.96	28.56	15.98	12.55
EBITA, 1 Yr. Growth %	31.8	-17.63	32.57	17.45	11.61
EBIT, 1 Yr. Growth %	26.38	-25.19	37.63	19.47	11.88
Earnings From Cont. Operations, 1 Yr. Growth %	18.15	-31.18	50.28	35.87	3.56
Net Income, 1 Yr. Growth %	18.25	-30.74	49.78	36.17	3.62
Normalized Net Income, 1 Yr. Growth %	21.4	-28.25	46.55	22.68	11.14
Diluted EPS Before Extra, 1 Yr. Growth %	17.93	-30.86	49.55	35.88	3.42
Accounts Receivable, 1 Yr. Growth %	28.03	-17.06	9.29	13.85	25.61
Inventory, 1 Yr. Growth %	23.46	-35.66	10.36	-3.15	21.37
Net Property, Plant and Equip., 1 Yr. Growth %	37.76	-6.01	-14.11	-2.22	44.22
Total Assets, 1 Yr. Growth %	41.65	1.65	2.95	10.62	15.8
Tangible Book Value, 1 Yr. Growth %	-50.23	38.83	31.11	37.8	28.67
Common Equity, 1 Yr. Growth %	21.12	10.97	10.98	17.49	15.44
Cash From Operations, 1 Yr. Growth %	12.19	2.09	17.39	6.27	11.73
Capital Expenditures, 1 Yr. Growth %	164.61	-61.2	40.13	-13.43	277.07
Levered Free Cash Flow, 1 Yr. Growth %	-121.55	-637.82	20.91	12.22	-13.19
Unlevered Free Cash Flow, 1 Yr. Growth %	-114.68	-916.05	18.18	10.67	-12.74
Dividend Per Share, 1 Yr. Growth %	-40	0	100	0	-41.67
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	25.26	12.94	3.28	10.47	11.39
Gross Profit, 2 Yr. CAGR %	24.15	13.29	4.66	12.51	13.36
EBITDA, 2 Yr. CAGR %	29.87	5.18	4.56	22.11	14.25
EBITA, 2 Yr. CAGR %	32.41	4.2	4.5	24.78	14.49
EBIT, 2 Yr. CAGR %	29.56	-2.77	1.47	28.23	15.61
Earnings From Cont. Operations, 2 Yr. CAGR %	24.06	-9.83	1.7	42.89	18.62
Net Income, 2 Yr. CAGR %	23.54	-9.5	1.85	42.81	18.79
Normalized Net Income, 2 Yr. CAGR %	24.49	-6.67	2.54	34.09	16.77
Diluted EPS Before Extra, 2 Yr. CAGR %	23.24	-9.7	1.68	42.55	18.55
Accounts Receivable, 2 Yr. CAGR %	28.91	3.04	-4.8	11.54	19.59
Inventory, 2 Yr. CAGR %	-3.96	-10.87	-15.74	3.38	8.42
Net Property, Plant and Equip., 2 Yr. CAGR %	19.28	13.79	-10.15	-8.36	18.75
Total Assets, 2 Yr. CAGR %	30.85	19.83	2.3	6.72	13.18
Tangible Book Value, 2 Yr. CAGR %	-22.45	-16.87	34.92	34.41	33.16
Common Equity, 2 Yr. CAGR %	20.84	15.69	10.97	14.19	16.46
Cash From Operations, 2 Yr. CAGR %	25.44	7.02	9.47	11.69	8.96
Capital Expenditures, 2 Yr. CAGR %	41.31	1.33	-26.26	10.14	80.67
Levered Free Cash Flow, 2 Yr. CAGR %	-43.73	7.66	155.01	16.26	-1.3
Unlevered Free Cash Flow, 2 Yr. CAGR %	-53.86	9.44	210.55	14.15	-1.73
Dividend Per Share, 2 Yr. CAGR %	0	-22.54	41.42	41.42	8.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	20.15	14.88	12.09	5.65	11.06
Gross Profit, 3 Yr. CAGR %	18.17	14.09	13.42	6.84	13.47
EBITDA, 3 Yr. CAGR %	21.7	12.78	12.46	8.24	18.84
EBITA, 3 Yr. CAGR %	23.09	13.03	12.91	8.65	20.23
EBIT, 3 Yr. CAGR %	21.15	7.88	9.17	7.14	22.53
Earnings From Cont. Operations, 3 Yr. CAGR %	20.45	1.94	6.91	12.01	28.35
Net Income, 3 Yr. CAGR %	20.08	1.87	7.05	12.21	28.33
Normalized Net Income, 3 Yr. CAGR %	16.35	3.6	8.48	8.86	25.96
Diluted EPS Before Extra, 3 Yr. CAGR %	19.85	1.64	6.83	12	28.09
Accounts Receivable, 3 Yr. CAGR %	17.07	11.29	5.08	1.05	16.05
Inventory, 3 Yr. CAGR %	22.57	-15.96	-4.29	-11.73	9.06
Net Property, Plant and Equip., 3 Yr. CAGR %	38	10.17	3.6	-7.58	6.6
Total Assets, 3 Yr. CAGR %	29.22	20.18	13.92	5	9.66
Tangible Book Value, 3 Yr. CAGR %	-15.17	-5.83	-3.24	35.87	32.47
Common Equity, 3 Yr. CAGR %	16.84	17.29	14.1	13.11	14.6
Cash From Operations, 3 Yr. CAGR %	26.91	17.12	10.37	8.39	11.7
Capital Expenditures, 3 Yr. CAGR %	39.26	-8.15	12.89	-22.21	66
Levered Free Cash Flow, 3 Yr. CAGR %	-33.9	19.42	11.91	93.71	5.47
Unlevered Free Cash Flow, 3 Yr. CAGR %	-41.24	20.21	12.28	119.9	4.38
Dividend Per Share, 3 Yr. CAGR %	25.99	0	6.27	25.99	32.64
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	18	13.8	13.1	13.09	11.81
Gross Profit, 5 Yr. CAGR %	16.54	12.37	12.57	13.46	13.4
EBITDA, 5 Yr. CAGR %	17.35	11.33	14.53	16.42	13.17
EBITA, 5 Yr. CAGR %	17.78	11.18	15.29	17.59	13.54
EBIT, 5 Yr. CAGR %	16.67	8.02	12.85	15.6	11.7
Earnings From Cont. Operations, 5 Yr. CAGR %	17.62	7.02	12.56	16.68	11.45
Net Income, 5 Yr. CAGR %	17.4	6.95	12.43	16.61	11.6
Normalized Net Income, 5 Yr. CAGR %	14.54	5.2	10.62	14.86	11.72
Diluted EPS Before Extra, 5 Yr. CAGR %	17.01	6.66	12.22	16.37	11.37
Accounts Receivable, 5 Yr. CAGR %	15.36	11.47	7.78	11.39	10.66
Inventory, 5 Yr. CAGR %	24.02	4.34	5.51	-8.7	0.6
Net Property, Plant and Equip., 5 Yr. CAGR %	28.32	18.99	16.23	2.35	9.42
Total Assets, 5 Yr. CAGR %	27.81	21.11	17.63	14.6	13.62
Tangible Book Value, 5 Yr. CAGR %	-0.06	0.54	2.13	8.57	9.94
Common Equity, 5 Yr. CAGR %	20.42	16.16	14.36	16.04	15.04
Cash From Operations, 5 Yr. CAGR %	21.13	18.27	19.62	14.91	9.81
Capital Expenditures, 5 Yr. CAGR %	17.74	-10.18	7.99	-1.23	36.25
Levered Free Cash Flow, 5 Yr. CAGR %	-13.58	26.35	13.43	18.14	6.34
Unlevered Free Cash Flow, 5 Yr. CAGR %	-19.49	27.91	14.37	17.75	6.37
Dividend Per Share, 5 Yr. CAGR %	31.95	21.67	31.95	14.87	6.96